Colin Walters

Title: **Colin Walters: Innovator in Pharmaceutical Research**

Introduction

Colin Walters is a notable inventor based in Monroe Township, NJ. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for cancer. His work exemplifies the spirit of modern invention, aiming to improve health outcomes through advanced medical formulations.

Latest Patents

Colin Walters holds a patent for his formulation of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione. This patent encompasses pharmaceutical compositions and single unit dosage forms of Compound A, including its enantiomers, pharmaceutically acceptable salts, solvates, hydrates, co-crystals, clathrates, and polymorphs. The focus of this patent is on methods for treating, managing, or preventing cancer, thereby showcasing his commitment to addressing critical health issues.

Career Highlights

Colin Walters has built an impressive career at Celgene Corporation, where he has been able to harness his inventive skills to push the boundaries of pharmaceutical research. His dedication to innovation has not only earned him patents but has also contributed to the broader mission of Celgene in advancing therapeutic solutions for patients.

Collaborations

Throughout his career, Colin has collaborated with esteemed colleagues such as William Bowen and Yali Sun. These partnerships have fostered a collaborative environment that enhances creativity and leads to impactful discoveries in the realm of pharmaceutical advancements.

Conclusion

Colin Walters stands out as an inventor with a crucial role in the development of innovative cancer treatments. His patent and collaborative efforts reflect a deep commitment to advancing healthcare through scientific research and innovation. As pharmaceutical challenges evolve, inventors like Colin play a vital role in creating solutions that improve the lives of patients globally.